Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Syntopix Group, a company into topical antimicrobial innovations for products in the medicine and consumer health care markets, has signed an agreement with Sinclair Pharmacy, an international specialty pharmacy company, to identify an antimicrobial compound to synergise the activity of a key product for Sinclair.
Subscribe to our email newsletter
Sinclair Pharmacy is expected to work in conjunction with Syntopix to develop a product. Should the collaboration result in a product that reaches commercialisation, financial gains from the sales will be shared between the two companies.
Stephen Jones, CEO of Syntopix, says: “We are delighted to be entering into this collaboration with Sinclair Pharmacy. I am very confident that its proprietary compound will be complemented and enhanced by some of the compounds that Syntopix has been identifying in this area over several years. We look forward to sharing exciting compounds and technical expertise with the intention of developing a health care product.”